help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jensen, M. D.
Right arrow Articles by Miles, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jensen, M. D.
Right arrow Articles by Miles, J. M.

Journal of Clinical Endocrinology & Metabolism, Vol 72, 308-315, Copyright © 1991 by Endocrine Society


ARTICLES

Effects of glucagon on free fatty acid metabolism in humans

MD Jensen, VJ Heiling and JM Miles
Department of Medicine, Mayo Medical School, Rochester, Minnesota 55905.

To determine whether physiological changes in plasma glucagon concentrations are important in regulating basal adipose tissue lipolysis, FFA flux ([1-14C]palmitate) was measured in response to increases and decreases in plasma glucagon. Eight volunteers with insulin-dependent diabetes mellitus (IDDM) and nine healthy nondiabetic volunteers were studied using the pancreatic clamp technique to control plasma insulin, GH, and glucagon concentrations at desired levels. Palmitate flux at the chosen euglucagonemic hormone infusion rates was similar to baseline values (1.73 +/- 0.12 vs. 1.75 +/- 0.23 and 1.35 +/- 0.18 vs. 1.35 +/- 0.16 mumol/kg.min, respectively, in IDDM and nondiabetic subjects). No significant changes in palmitate flux occurred in response to glucagon withdrawal or mild (nondiabetic volunteers) or high physiological (IDDM volunteers) hyperglucagonemia. Thus, under conditions of normal FFA availability, changes in plasma glucagon concentrations within the physiological range have little or no effect on adipose tissue lipolysis.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
N. Rivera, C. A. Everett-Grueter, D. S. Edgerton, T. Rodewald, D. W. Neal, E. Nishimura, M. O. Larsen, L. O. Jacobsen, K. Kristensen, C. L. Brand, et al.
A Novel Glucagon Receptor Antagonist, NNC 25-0926, Blunts Hepatic Glucose Production in the Conscious Dog
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 743 - 752.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
R. A. Nafikov, B. N. Ametaj, G. Bobe, K. J. Koehler, J. W. Young, and D. C. Beitz
Prevention of Fatty Liver in Transition Dairy Cows by Subcutaneous Injections of Glucagon
J Dairy Sci, May 1, 2006; 89(5): 1533 - 1545.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Nielsen, N. Moller, S. B. Pedersen, J. S. Christiansen, and J. O. L. Jorgensen
The Effect of Long-Term Pharmacological Antilipolysis on Substrate Metabolism in Growth Hormone (GH)-Substituted GH-Deficient Adults
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3274 - 3278.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. H. Gravholt, N. Møller, M. D. Jensen, J. S. Christiansen, and O. Schmitz
Physiological Levels of Glucagon Do Not Influence Lipolysis in Abdominal Adipose Tissue as Assessed by Microdialysis
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2085 - 2089.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Bertin, P. Arner, J. Bolinder, and E. Hagström-Toft
Action of Glucagon and Glucagon-Like Peptide-1-(7-36) Amide on Lipolysis in Human Subcutaneous Adipose Tissue and Skeletal Muscle in Vivo
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1229 - 1234.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Shah, A. Basu, R. Basu, and R. Rizza
Impact of lack of suppression of glucagon on glucose tolerance in humans
Am J Physiol Endocrinol Metab, August 1, 1999; 277(2): E283 - E290.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. T. Donahoo, D. R. Jensen, T. J. Yost, and R. H. Eckel
Isoproterenol and Somatostatin Decrease Plasma Leptin in Humans: A Novel Mechanism Regulating Leptin Secretion
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4139 - 4143.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society